News Release

Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTC US: IZOZF) (FSE: 1R3) is pleased to highlight the appointment of Director and Principal Founder of Breast CT Technology, Dr. John M. Boone, as the Editor-In-Chief of the American Association of…...

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company", "Sona") a developer of rapid, point-of-care diagnostic tests, has been granted CE Mark status for its rapid, COVID-19 antigen test. The CE Mark declares the conformity of the Sona test with…...

Garibaldi Resources Corp. (TSXV: GGI) (the "Company" or "Garibaldi") is pleased to announce results from the recently completed 2020 drill program, targeting deeper extensions of the easterly plunging E&L intrusion. Building along trend of the expanding 650 meter long E&L…...

Canada Silver Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (the "Company" or "Canada Silver Cobalt") is pleased to announce the intersection of a new, additional, high-grade silver vein within 60 metres of the Robinson Zone Discovery hole CA-1108.…...

Granada Gold Mine Inc. (TSXV: GGM) (the "Company" or "Granada") is pleased to provide an update on its on-going drill program at Granada. This release contains drill results from the 100-series part 2, near-surface drill program targeting Vein 1....

Sassy Resources Corporation (“Sassy” or the “Company”) (CSE: SASY) (FSE: 4E7) (OTCQB: SSYRF) is pleased to provide an exploration update including Phase 1 drill results for its 146 sq. km and 100%-owned Foremore Project in Northwest B.C.’s prolific Eskay Camp…...

Canada Silver Cobalt Works Inc. (TSXV: CCW) (OTC: CCWOF) (Frankfurt: 4T9B) (the "Company" or "Canada Silver Cobalt") is pleased to announce that Canada Silver Cobalt Works intersected high-grade gold mineralisation with cobalt within the high-grade silver-cobalt mineralized vein structures at…...

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company", "Sona") a developer of rapid, point-of-care diagnostic tests, is pleased to announce that it has closed its non-brokered private placement that was announced on December 3, 2020 with the issuance of…...

Izotropic Corporation ("Izotropic" or the "Company") (CSE: IZO) (OTC US: IZOZF) (FSE: 1R3) announces it has received the finalized meeting minutes from the U.S. Food and Drug Administration (FDA) in connection with the Company's recent pre-submission meeting and the market…...

Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) is pleased to announce that it has completed a non-brokered private placement financing (the “Offering”) of 1,896,679 units of the Company (each, a “Unit”) at a price of $0.90 per Unit for…...